Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,897 | -16,312 | -11,812 | -8,035 | -6,088 |
| Depreciation Amortization | 7 | 24 | 17 | 11 | 5 |
| Income taxes - deferred | N/A | 865 | -31 | -170 | -87 |
| Accounts receivable | 113 | -614 | -32 | -9 | -1 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 2 | N/A |
| Other Working Capital | 28 | 636 | -808 | -3,166 | -1,527 |
| Other Operating Activity | 252 | 8,004 | 5,728 | 4,943 | 4,702 |
| Operating Cash Flow | $-1,498 | $-7,398 | $-6,937 | $-6,424 | $-2,994 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -120 | -120 | -115 | -93 |
| Purchase Of Investment | N/A | -1,602 | -1,519 | N/A | N/A |
| Investing Cash Flow | $N/A | $-1,722 | $-1,638 | $-115 | $-93 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 350 | 350 | N/A | N/A |
| Debt Issued | 3,207 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 3,664 | 3,917 | 3,664 | N/A |
| Other Financing Activity | -1,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $2,207 | $4,014 | $4,267 | $3,664 | $0 |
| Exchange Rate Effect | -309 | -67 | -287 | -91 | -45 |
| Beginning Cash Position | 1,392 | 6,565 | 6,565 | 6,565 | 6,565 |
| End Cash Position | 1,792 | 1,392 | 1,970 | 3,599 | 3,433 |
| Net Cash Flow | $400 | $-5,174 | $-4,595 | $-2,966 | $-3,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,498 | -7,398 | -6,937 | -6,424 | -2,994 |
| Capital Expenditure | N/A | -120 | -120 | -115 | -93 |
| Free Cash Flow | -1,498 | -7,518 | -7,057 | -6,539 | -3,088 |